Association of alcohol consumption with white blood cell count: A study of Japanese male office workers

Journal of Internal Medicine

Volumn 253, Issue 3, 2003, Pages 367-374

  Nakanishi, Noriyuki ^a   Yoshida, H ^a   Okamoto, M ^a   Matsuo, Y ^a   Suzuki, K ^b   Tatara, K ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Japan Labor and Welfare Association   (Japan)

Author keywords

Alcohol intake; Japanese men; Smoking status; White blood cell count

Indexed keywords

ALCOHOL; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CONFIDENCE INTERVAL; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HUMAN; JAPAN; LEUKOCYTE COUNT; MALE; MEDICAL EXAMINATION; OFFICE WORKER; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING; SYSTOLIC BLOOD PRESSURE; BLOOD; BLOOD PRESSURE; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; DRINKING BEHAVIOR; MIDDLE AGED; RISK FACTOR;

ADULT; ALCOHOL DRINKING; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CHOLESTEROL; CHOLESTEROL, HDL; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; RISK FACTORS; SMOKING;

EID: 0037337972     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2003.01112.x     Document Type: Article

References (44)

1. Klatsky AL, Friedman GD, Siegelaub AB. Alcohol and mortality. A ten-year Kaiser-Permanente experience. Ann Intern Med 1981; 95: 139-45.
2. Rosengren A, Wilhelmsen L, Wedel H. Separate and combined effects of smoking and alcohol abuse in middle-aged men. Acta Med Scand 1988; 223: 111-8.
3. Doll R, Peto R, Hall E, Wheatley K. Gray R. Mortality in relation to consumption of alcohol: 13 years' observations on male British doctors. BMJ 1994; 309: 911-8.
4. White IR. The level of alcohol consumption at which all-cause mortality is least. J Clin Epidemiol 1999; 52: 967-75.
5. Grønbaek M, Deis A, Sorensen TI et al. Influence of sex, age, body mass index, and smoking on alcohol intake and mortality. BMJ 1994; 308: 302-6.
6. Gaziano JM, Gaziano TA, Glynn RJ et al. Light-to-moderate alcohol consumption and mortality in the Physicians' Health Study enrolment cohort. J Am Coll Cardiol 2000; 35: 96-105.
7. Gaziano JM, Buring JE, Breslow JL et al. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N Engl J Med 1993; 329: 1829-34.
8. Rimm EB, Williams P, Fosher K, Criqui M, Stampfer MJ, Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ 1999; 319: 1523-8.
9. Mayer EJ, Newman B, Quesenberry CP Jr, Friedman GD, Selby JV. Alcohol consumption and insulin concentrations. Role of insulin in associations of alcohol intake with high-density lipoprotein cholesterol and triglycerides. Circulation 1993; 88: 2190-7.
10. Facchini F, Chen YD, Reaven GM. Light-to-moderate alcohol intake is associated with enhanced insulin sensitivity. Diabetes Care 1994; 17: 115-9.
11. Bell DS. Alcohol and the NIDDM patient. Diabetes Care 1996; 19: 509-13.
12. Ridker PM, Vaughan DE, Stampfer MJ, Glynn RJ. Hennekens CH. Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activator. JAMA 1994; 272: 929-33.
13. Díaz LE, Montero A, González-Gross M, Vallejo AI, Romeo J, Marcos A. Influence of alcohol consumption on immunological status: a review. Eur J Clin Nutr 2002; 56 (Suppl. 3): S50-3.
14. Friedman GD, Klatsky AL. Is alcohol good for your health? N Engl J Med 1993; 329: 1882-3.
15. Deutscher S, Rockette HE, Krishnaswami V. Evaluation of habitual excessive alcohol consumption on myocardial infarction risk in coronary disease patients. Am Heart J 1984; 108: 988-95.
16. Fraser GE, Upsdell M. Alcohol and other discriminants between cases of sudden death and myocardial infarction. Am J Epidemiol 1981; 114: 462-76.
17. Nelson S, Kolls JK. Alcohol, host defence and society. Nat Rev Immunol 2002; 2: 205-9.
18. Szabo G. Consequences of alcohol consumption on host defence. Alcohol Alcohol 1999; 34: 830-41.
19. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-26.
20. Munro JM, Cotran RS. The pathogenesis of atherosclerosis: atherogenesis and inflammation. Lab Invest 1988; 58: 249-61.
21. Boyle JJ. Association of coronary plaque rupture and atherosclerotic inflammation. J Pathol 1997; 181: 93-9.
22. Friedman GD, Klatsky AL, Siegelaub AB. The leukocyte count as a predictor of myocardial infarction. N Engl J Med 1974; 290: 1275-8.
23. Yarnell JW, Baker IA, Sweetnam PM et al. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies. Circulation 1991; 83: 836-44.
24. Weijenberg MP, Feskens EJ, Kromhout D. White blood cell count and the risk of coronary heart disease and all-cause mortality in elderly men. Arterioscler Thromb Vasc Biol 1996; 16: 499-503.
25. Friedman GD, Tekawa I, Grimm RH, Manolio T, Shannon SG, Sidney S. The leucocyte count: correlates and relationship to coronary risk factors: the CARDIA study. Int J Epidemiol 1990; 19: 889-93.
26. Nieto FJ, Szklo M, Folsom AR, Rock R, Mercuri M. Leukocyte count correlates in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol 1992; 136: 525-37.
27. Targher G, Seidell JC, Tonoli M, Muggeo M, De Sandre G, Cigolini M. The white blood cell count: its relationship to plasma insulin and other cardiovascular risk factors in healthy male individuals. J Intern Med 1996; 239: 435-41.
28. Nakanishi N, Suzuki K, Tatara K. White blood cell count and clustered features of metabolic syndrome in Japanese male office workers. Occup Med 2002; 52: 213-8.
29. DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 173-94.
30. Ferrannini E, Haffner SM, Mitchell BD, Stern MP. Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 1991; 34: 416-22.
31. Gray RS, Fabsitz RR, Cowan LD, Lee ET, Howard BV, Savage PJ. Risk factor clustering in the insulin resistance syndrome. The Strong Heart Study. Am J Epidemiol 1998; 148: 869-78.
32. Carantoni M, Zuliani G, Volpato S et al. Relationships between fasting plasma insulin, anthropometrics, and metabolic parameters in a very old healthy population. Associazione Medica Sabin. Metabolism 1998; 47: 535-40.
33. Nakanishi N, Makino K, Nishina K, Suzuki K, Tatara K. Relationship of light to moderate alcohol consumption and risk of hypertension in Japanese male office workers. Alcohol Clin Exp Res 2002; 26: 988-94.
34. Nakanishi N, Sato M, Shirai K, Suzuki K, Tatara K, White Blood cell count as a risk factor for hypertension: a study of Japanese male office workers. J Hypertens 2002; 20: 851-7.
35. Corre F, Lellouch J, Schwartz D. Smoking and leucocytecounts. Results of an epidemiological survey. Lancet 1971; 2: 632-4.
36. Friedman GD, Siegelaub AB, Seltzer CC, Feldman R, Collen MF. Smoking habits and the leukocyte count. Arch Environ Health 1973; 26: 137-43.
37. Sunyer J, Munoz A, Peng Y et al. Longitudinal relation between smoking and white blood cells. Am J Epidemiol 1996; 144: 734-41.
38. Imhof A, Froehlich M, Brenner H, Boeing H, Pepys MB, Koenig W. Effect of alcohol consumption on systemic markers of inflammation. Lancet 2001; 357: 763-7.
39. Sim E. Humoral Factors. Oxford: IRL Press. 1993.
40. Zhang Z, Cork JYeP, Lei D, Schwarzenberger PO, Summer WR et al. Inhibition of TNF-alpha processing and TACE-mediated ectodomain shedding by ethanol. J Leukoc Biol 2000; 67: 856-62.
41. Nelson S, Bagby GJ, Bainton BG, Summer WR. The effects of acute and chronic alcoholism on tumor necrosis factor and the inflammatory response. J Infect Dis 1989; 160: 422-9.
42. Mendall MA, Patel P, Asante M et al. Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease. Heart 1997; 78: 273-7.
43. McCarty MF. Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes, and visceral obesity: down-regulation with essential fatty acids, ethanol and pentoxifylline. Med Hypotheses 1999; 52: 465-77.
44. McClain CJ, Barve S, Deaciuc I, Kugelmas M, Hill D. Cytokines in alcoholic liver disease. Semin Liver Dis 1999; 19: 205-19.